AIOMEGA Launches Breathe Academy for OSA Devices Training

TYLER, TX, UNITED STATES, October 1, 2026 /CourierPR/ -- AIOMEGA, a medical technology company focused on growth-responsive airway stabilization for pediatric and adult obstructive sleep apnea, has announced the launch of the AIOMEGA Breathe Academy. The Academy is a clinician training program designed to support the company’s FDA-cleared wearable oral devices for airway stabilization, including the AIO Breathe for adults and the AIO Breathe PDS for children.

The AIOMEGA Breathe Academy is built around the company’s two FDA-cleared wearable oral devices and the clinician-directed prescription tools that support their implementation. The AIO Breathe is an FDA-cleared oral device for adult OSA, supported by a clinician-controlled prescription pathway and a non-titration treatment approach aimed at eliminating the need for recurrent titration. The AIO Breathe PDS is an FDA-cleared pediatric wearable oral device for OSA, designed for growth-responsive alignment and sequential airflow improvement during craniofacial development. There is no need for a posterior leaning flange (PLL) option when prescribing AIO Breathe devices, as the device itself does not change; the PLL is a prescriptive option within the FDA-cleared design.

Clinicians may specify a posterior leaning flange angle greater than 90 degrees when prescribing AIO Breathe devices. The device itself does not change; the PLL is a prescriptive option within the FDA-cleared design. This option supports airway stability in both adult and pediatric pathways and is included in the Academy training.

The AIOMEGA Breathe Academy is designed to provide structured education, certification pathways, and clinical implementation guidance for clinicians across various medical fields, including hospital systems, sleep centers, ENT practices, dental sleep medicine providers, orthodontists, and dentists specialized in temporomandibular joint disorders (TMD). The Academy integrates AIOMEGA’s clinician-controlled guidance tools, including AIO Rx, SMART Rx, and the AIOMEGA Clinical Guidance System, which supports reproducible, clinician-directed prescription planning for both adult and pediatric pathways.

The AIOMEGA Breathe Academy connects the company’s FDA-cleared adult and pediatric devices with a structured training system that supports safe, consistent implementation across clinical settings. The Academy ensures clinicians can adopt these pathways safely and consistently, providing structured training in adult and pediatric implementation pathways, multi-segment collapsibility assessment, airway behavior interpretation, stability testing protocols, clinical documentation standards, guidance system training for AIO Rx and SMART Rx, and the integration of the AIOMEGA Clinical Guidance System.

AIOMEGA’s devices provide growth-responsive airway stabilization, clinician-guided prescription pathways, behavior-responsive airway mechanics, non-titration adult treatment options, and clinician-controlled implementation. The company’s devices support structured airway stabilization treatment options supported by PDAC CMS approval. The AIOMEGA Breathe Academy is designed for pediatric sleep medicine, ENT and pulmonology, dental sleep medicine, orthodontics, dentists specialized in TMD, hospital systems, and youth athlete airway programs.

The AIOMEGA App, a subscription-based digital platform, is designed for patients and athletes to track sleep, health, wellness, and performance. The app is therapy agnostic and can be used whether a patient is using a wearable oral device, another manufacturer’s device, or no device at all. The AIOMEGA App does not sense or measure physiological signals on its own; instead, it collates and displays data retrieved from user inputs or from external wearables selected by the patient or athlete. Features include nutrition tracking, sleep architecture, weight loss or weight gain goal setting, exercise tracking, and performance reflection tools for athletes.

Patients and athletes may download the app independently. Clinicians, dentists, or coaches may invite users to share their data; access is only granted if the user accepts the invitation. The AIOMEGA App is not part of the FDA-cleared devices and does not modify their intended use.